Arnhold LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,113 filers reported holding NOVARTIS A G in Q2 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
Arnhold LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$1,287,103
+0.9%
12,6360.0%0.15%
+5.5%
Q2 2023$1,275,099
+9.7%
12,6360.0%0.14%
+9.8%
Q1 2023$1,162,512
-18.0%
12,636
-19.2%
0.13%
-23.7%
Q4 2022$1,418,498
+19.4%
15,6360.0%0.17%
+8.1%
Q3 2022$1,188,000
-10.1%
15,6360.0%0.16%
+1.3%
Q2 2022$1,322,000
-3.6%
15,6360.0%0.16%
+2.6%
Q1 2022$1,372,000
+24.2%
15,636
+23.7%
0.15%
+23.2%
Q4 2021$1,105,000
-13.6%
12,636
-19.2%
0.12%
-15.5%
Q3 2021$1,279,000
-10.4%
15,6360.0%0.15%
-8.6%
Q2 2021$1,427,000
+6.7%
15,6360.0%0.16%
+1.2%
Q1 2021$1,337,000
-10.7%
15,636
-1.3%
0.16%
-17.5%
Q4 2020$1,497,000
+8.6%
15,8480.0%0.19%
-4.4%
Q3 2020$1,378,000
-0.4%
15,8480.0%0.20%
-7.7%
Q2 2020$1,384,000
+5.9%
15,8480.0%0.22%
-8.7%
Q1 2020$1,307,000
-12.9%
15,8480.0%0.24%
+1.7%
Q4 2019$1,501,000
+9.0%
15,8480.0%0.24%
+1.3%
Q3 2019$1,377,000
-4.8%
15,8480.0%0.23%
-7.9%
Q2 2019$1,447,000
-5.1%
15,8480.0%0.25%
-7.3%
Q1 2019$1,524,000
+12.1%
15,8480.0%0.27%
+8.3%
Q4 2018$1,360,000
-0.4%
15,8480.0%0.25%
+7.7%
Q3 2018$1,365,000
+14.0%
15,8480.0%0.24%
+11.4%
Q2 2018$1,197,000
-6.6%
15,8480.0%0.21%
-12.8%
Q1 2018$1,281,00015,8480.24%
Other shareholders
NOVARTIS A G shareholders Q2 2021
NameSharesValueWeighting ↓
MANAGED ASSET PORTFOLIOS, LLC 237,047$19,165,0006.16%
PRENTISS SMITH & CO INC 127,005$10,268,0005.38%
EXENCIAL WEALTH ADVISORS, LLC 195,903$15,839,0004.71%
Osher Van de Voorde Investment Management 106,315$8,596,0004.37%
BROWN BROTHERS HARRIMAN & CO 8,924,544$721,549,0004.16%
CGOV Asset Management 874,998$70,744,0004.08%
PROFESSIONAL ADVISORY SERVICES INC 218,844$17,694,0003.83%
COMPASS CAPITAL MANAGEMENT, INC 304,931$24,654,0003.69%
First Fiduciary Investment Counsel, Inc. 226,636$18,324,0003.64%
SUMMITRY LLC 456,575$36,914,0003.41%
View complete list of NOVARTIS A G shareholders